Kezar Life Sciences (KZR) said Monday it will implement a reverse stock split at a ratio of 1-for-10.
The shares will start trading on a post-split basis on Oct. 30, the company said.
The split is part of a plan to regain compliance with Nasdaq's minimum bid price rule of $1 per share, the company said.
Shares of Kezar Life Sciences were down 1.4% in recent trading.
Price: 0.77, Change: -0.01, Percent Change: -1.39
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。